Discussing the Future of Drug Development and the Pharmaceutical Marketplace (original) (raw)
Related papers
A Vision of Pharmacy's Future Roles, Responsibilities, and Manpower Needs in the United States
Pharmacotherapy, 2000
Purpose This White Paper examines the pharmacy profession's future. It discusses pharmacy's changing philosophy of practice, factors influencing the evolution of professional roles and responsibilities, preparation for future roles, future leadership and management needs, workforce manpower projections, and qualifications for practice. The paper projects a vision for this future and provides recommendations to the profession and to the American College of Clinical Pharmacy (ACCP).
American Journal of Pharmaceutical Education, 2020
EXECUTIVE SUMMARY The 2019-2020 Academic Affairs Committee was charged with identifying promising practices in academic-practice partnerships and professional pharmacy organization initiatives that are accelerating the transformation of a workforce prepared to assume responsibility for society’s medication use needs in 2030 and determining the role AACP can plan in supporting these partnerships and initiatives. The committee identified a set of ideal principles, characteristics, and design elements of a high-quality, large-scale workforce development program. The committee also categorized current mechanisms for professional workforce development, in addition to identifying their strengths and weaknesses, with the realization that novel approaches are needed to accomplish the goal of large-scale workforce transformation. This report also highlights two existing initiatives aligned with accelerating the transformation of the workforce (ie, the Community Pharmacy Enhanced Services N...
Catalysts For Change: Will Pharmacy in the United States Embrace Them
International Journal of Pharma Research and Health Sciences, 2015
Objectives:To briefly discuss previous paradigm change calls for pharmacy practice to move toward a more patient-focused profession, and to make the case that several catalysts are in place to move toward a more patient-focused profession in the near future. Summary: From Eugene White’s “Office Based” practice model to Helpler and Strand’s“Pharmaceutical Care” model, during the past 50 years there have been no shortage of expert advocates for the pharmacy profession moving toward a patient-focused one. The results so far have not been as optimal as many would have hoped. An argument is made that the confluence of the passage of the Affordable Care Act, pharmacist manpower stability(and fear by many of an impending oversupply), and the imminent and future impact of automation and technology serve as excellent catalysts to influence the profession to move much more rapidly toward the patient-focused care paradigm.Conclusion:The profession must embrace the opportunities discussed regarding moving quickly toward the patient-focused paradigm. Although several barriers still exist, especially in the community setting, it is difficult to see a path whereby pharmacy can rely on dispensing for its livelihood to the extent it has historically. Therefore,the profession has little choice but to embrace the role of the pharmacotherapy expert in collaborative health care practice.
A New Paradigm for Pharmacy Practice and Education
2006
Pharmacy practice is currently undergoing a paradigm shift from a productcentered distribution activity to a patient-centered system by which pharmacists are assuming new responsibilities, helping patients achieve healthy outcomes, and providing value previously unrecognized by the health care system. In order to accomplish this paradigm shift, the pharmacy profession must establish new relationships with both patients and their health care providers to assure better outcomes. To accomplish this goal, the health care system needs to be refined to assure appropriate selection, use, and monitoring of pharmaceutical drug products. Our present health care system of drug prescribing, dispensing, administration, and consumption frequently results in drug therapy outcomes that are less effective, appropriate, safe, and economical than is desired. There are impressive and undeniable amounts of evidence that support the premise that drug-related adverse events are all too pervasive and costl...
The Strategic Plan of the American College of Clinical Pharmacy 1994–1996
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
The Strategic Plan of the American College of Clinical Pharmacy The strategic planning process of the American College of Clinical Pharmacy typically occurs on a three-to five-year cycle. Every fourth or fifth year, ACCP organizes a major planning initiative that includes a broad representation of its membership. This initiative updates and creates a new strategic plan, identifies goals and objectives, and begins the process of developing action-oriented strategies to achieve the stated objectives. In the interim, the ACCP Board of Regents, Research Institute Board of Trustees, and Pharmacotherapy Board of Directors assume primary responsibility for establishing priorities, working on selected goals and objectives, monitoring progress, and refining the plan as needed to reflect changes in environmental conditions. Over 1000 ACCP members have provided input to the College's strategic plan by participating in surveys, focus groups, and strategic planning retreats. The goal of ACCP's strategic planning effort is to develop, implement, and monitor an integrated strategic plan for all facets of the organization. This requires a shared vision of where we are trying to move the entire organization while recognizing that the individual missions of ACCP, the Research Institute, and Pharmacotherapy all contribute to achieving this vision in their unique ways. The process and timeline used to develop this planning document are depicted in Figure 1.